# Drugs@FDA application ANDA208569

> The official Drugs@FDA dataset lists original submission 1 for ANDA 208569 with status AP dated 2023-11-16, and names teriparatide among the application record's active ingredients.

- Evidence object: `story:fda-drugs-anda208569:v1`
- Evidence domain: Regulatory
- Date in source: 2023-11-16
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/fda-drugs-anda208569/
- JSON record: https://peptidescanner.com/evidence/v1/objects/fda-drugs-anda208569-v1.json
- Content SHA-256: `57b4e3b948328c72abee8c3f19e6436ba4f5d6b964497d1e5fa8d7128b3195d1`

## Claims and source pins

### Headline

Drugs@FDA application ANDA208569 ([`fda-drugs-anda208569-2023-11-16-7415d9bf6641`](#source-fda-drugs-anda208569-2023-11-16-7415d9bf6641))

### Summary

The official Drugs@FDA dataset lists original submission 1 for ANDA 208569 with status AP dated 2023-11-16, and names teriparatide among the application record's active ingredients. ([`fda-drugs-anda208569-2023-11-16-7415d9bf6641`](#source-fda-drugs-anda208569-2023-11-16-7415d9bf6641))

### Paragraph 1

The official Drugs@FDA dataset lists original submission 1 for ANDA 208569 with status AP dated 2023-11-16, and names teriparatide among the application record's active ingredients. ([`fda-drugs-anda208569-2023-11-16-7415d9bf6641`](#source-fda-drugs-anda208569-2023-11-16-7415d9bf6641))

### Paragraph 2

This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance. ([`fda-drugs-anda208569-2023-11-16-7415d9bf6641`](#source-fda-drugs-anda208569-2023-11-16-7415d9bf6641))

## Sources

<a id="source-fda-drugs-anda208569-2023-11-16-7415d9bf6641"></a>
- **Drugs@FDA application ANDA208569 · original submission status AP · 2023-11-16 · dataset 2026-08-13** — Drugs@FDA via openFDA; class A. [Open source](https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22ANDA208569%22&limit=1) (`fda-drugs-anda208569-2023-11-16-7415d9bf6641`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Drugs@FDA application ANDA208569." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/fda-drugs-anda208569-v1.json SHA-256: 57b4e3b948328c72abee8c3f19e6436ba4f5d6b964497d1e5fa8d7128b3195d1.